Jounce Therapeutics, Inc. (JNCE): Price and Financial Metrics
JNCE Price/Volume Stats
| Current price | $1.88 | 52-week high | $5.87 |
| Prev. close | $1.93 | 52-week low | $0.58 |
| Day low | $1.88 | Volume | 11,600,600 |
| Day high | $1.93 | Avg. volume | 2,457,142 |
| 50-day MA | $1.59 | Dividend yield | N/A |
| 200-day MA | $1.99 | Market Cap | 98.95M |
JNCE Stock Price Chart Interactive Chart >
Jounce Therapeutics, Inc. (JNCE) Company Bio
Jounce Therapeutics, Inc. focuses on developing cancer immunotherapy treatments that enable the immune system to attack tumors. The company in 2012 and is based in Cambridge, Massachusetts.
JNCE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -77.32% |
| 5-year | -60.83% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -86.71% |
| 2021 | 19.29% |
| 2020 | -19.82% |
| 2019 | 159.05% |
Continue Researching JNCE
Want to see what other sources are saying about Jounce Therapeutics Inc's financials and stock price? Try the links below:Jounce Therapeutics Inc (JNCE) Stock Price | Nasdaq
Jounce Therapeutics Inc (JNCE) Stock Quote, History and News - Yahoo Finance
Jounce Therapeutics Inc (JNCE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...